Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial
Kevin L. Winthrop, Alan W. Skolnick, Adnan M. Rafiq, Scott H. Beegle, Julian Suszanski, Guenther Koehne, Ofra Barnett-Griness, Aida Bibliowicz, Reza Fathi, Patricia Anderson, Gilead Raday, Gina Eagle, Vered Katz Ben-Yair, Harold S. Minkowitz, Mark L. Levitt, Michael S. Gordon
doi: https://doi.org/10.1101/2021.08.23.21262464
